Skip to main content

Please wait ...

Michael Mithoefer, MD


Michael Mithoefer, MD, is clinical assistant professor of psychiatry at the Medical University of South Carolina. In 2009, he completed & published the first FDA approved clinical trial of MDMA assisted psychotherapy for treatment-resistant PTSD, followed by completion of a Phase II trial. He is overseeing a multisite Phase III study of MDMA-assisted psychotherapy in 13 sites around the US (including the Trauma Research Foundation), and another MDMA-assisted psychotherapy multisite study in Europe and Israel.

 

Speaker Disclosures:
Financial: Dr. Michael Mithoefer has employment relationships with Bassett Healthcare Network, Medical University of South Carolina, and MAPS Public Benefit Corporation. He has an ownership interest in Awakn Life Sciences and serves on the scientific advisory board. Dr. Mithoefer receives a speaking honorarium and recording royalties from PESI, Inc.
Non-financial: Dr. Michael Mithoefer is a fellow of the American Psychiatric Association.

Psychedelic-Assisted Therapy: Breakthrough Treatments for Complex Mental Health Disorders


Credit available - Click Here for more information

Speakers:
Peter H Addy, PhD, LPC, LMHC |  Michael Mithoefer, MD |  Gabor Maté, MD |  Janis Phelps, PhD
Duration:
15 Hours 8 Minutes
Copyright:
Jun 10, 2021
Product Code:
CRS001482
Media Type:
Online Course
Price:
$199.99 Standard - $609.95

Psychedelics in Therapy: New Ways to Catalyze Healing


Credit available - Click Here for more information

Speakers:
Michael Mithoefer, MD
Duration:
1 Hour 56 Minutes
Format:
Audio and Video
Copyright:
Jan 12, 2021
Product Code:
NOS096105
Media Type:
Digital Seminar
Price:
$119.99 - Standard

Emerging Psychedelic Treatments: Opportunities and Challenges


Credit available - Click Here for more information

Speakers:
Michael Mithoefer, MD |  Rick Doblin, PhD
Duration:
3 Hours 55 Minutes
Copyright:
Mar 12, 2022
Product Code:
NOS096211
Media Type:
Digital Seminar
Price:
$179.99 - Standard

Showing 1 to 4 of 4 entries